Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report

PURPOSE: This study presents patient-specific quality assurance (QA) results from the first 395 clinical cases for the new helical TomoTherapy® platform (Radixact) coupled with dedicated Precision TPS. METHODS: The passing rate of the Gamma Index (GP%) of 395 helical QA of patient-specific tomothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusella, Marco, Cavinato, Samuele, Germani, Alessandra, Paiusco, Marta, Pivato, Nicola, Rossato, Marco Andrea, Scott, Anthony, Scaggion, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607724/
https://www.ncbi.nlm.nih.gov/pubmed/34809645
http://dx.doi.org/10.1186/s13014-021-01952-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607724/
https://www.ncbi.nlm.nih.gov/pubmed/34809645
http://dx.doi.org/10.1186/s13014-021-01952-w

Ejemplares similares